Track the Structure Therapeutics Inc. share price and the full management transaction log of the company, a publicly traded company based in United States. Shares trade on the US market, under the oversight of SEC (Form 4). Market capitalisation: €3.8bn. The latest transaction was filed on 7 August 2026 (Attribution). Among the most active insiders: Lin Xichen. All data is openly available.
49
Insider Decl.
n/a
Thresholds
n/a
n/a
Buy Volume
n/a
n/a
Sell Volume
Analyst consensus: bullish or bearish?
Analysts rate Structure Therapeutics Inc. Strong Buy (bullish), based on 15 analysts. Average price target: US$104.77.
31Σ signal
This score ranks the purchase within its own market. No market currently meets the historical allocation criteria, so signals remain watch-only. Not investment advice.
Σ
Sigma AI Analysis
Fundamental view, insider signal, bull and bear case, synthesis.
1,824 shares@ US$7.9166100.0% of flowOrdinary SharesSEC:0001415889-25-019353:0
25 of 49 declarations
Acerca de Structure Therapeutics Inc.
Structure Therapeutics Inc. es una empresa biofarmacéutica centrada en el desarrollo de tratamientos para enfermedades metabólicas y trastornos relacionados con la salud. Emplea una plataforma de descubrimiento de fármacos para identificar nuevas terapias.